abil
fd
bacteriophag
particl
trigger
differ
arm
immun
system
previous
shown
us
particular
emphasi
abil
phage
rais
ctl
respons
vitro
vivo
show
fd
virion
absenc
adjuv
abl
evok
dth
reaction
mediat
antigen
specif
cell
addit
analyz
induct
ctl
respons
mice
deplet
cell
observ
shortterm
secondari
ctl
respons
induc
absenc
cell
induct
longterm
memori
ctl
requir
presenc
lymphocyt
result
examin
cellular
mechan
basi
fd
effici
provid
new
element
valid
use
fd
particl
elicit
monitor
antigenspecif
ctl
system
antigen
deliveri
bacteriophag
base
modif
phage
display
technolog
filament
bacteriophag
fd
well
understood
structur
genet
level
capsid
contain
one
major
protein
pviii
larg
alpha
helic
form
shingl
tubular
array
surround
singlestrand
viral
dna
ntermin
region
expos
viral
surfac
given
larg
number
pviii
protein
approxim
copi
per
virion
peptid
display
pviii
even
express
lower
copi
number
phage
particl
remain
dens
repres
good
evid
immunoassay
nmr
spectroscopi
expos
peptid
adopt
stabl
threedimension
structur
close
resembl
exhibit
wildtyp
parent
protein
unexpect
observ
fd
filament
bacteriophag
particl
taken
process
major
histocompat
mhc
class
pathway
abl
trigger
cytotox
lymphocyt
ctl
suggest
fd
virion
repres
effici
system
antigen
deliveri
investig
use
fd
virion
display
epitop
recogn
cell
mediat
delay
type
hypersensit
dth
reaction
demonstr
abil
fd
bacteriophag
elicit
dth
absenc
adjuv
addit
analyz
cell
subset
involv
induct
secondari
memori
ctl
respons
sinc
known
coexpress
link
helper
cell
cytotox
cell
epitop
surfac
antigenpres
cell
apc
requir
prime
ctl
respons
initi
design
hybrid
bacteriophag
simultan
display
helper
cytotox
epitop
virion
use
doubledisplay
bacteriophag
particl
show
bacteriophag
virion
abl
elicit
sustain
antigenspecif
ctl
respons
vitro
vivo
howev
studi
also
observ
singl
hybrid
phage
display
strong
ctl
epitop
ova
abl
induc
effici
ctl
respons
even
absenc
helper
exogen
epitop
hypothes
carrier
fd
may
also
contain
restrict
helper
epitop
journal
biomedicin
biotechnolog
latter
may
exert
suffici
helper
function
mice
strong
ctl
epitop
ova
display
fd
bacteriophag
better
address
issu
analyz
ctl
induct
singledisplay
fd
virion
mice
deplet
cell
singl
hybrid
bacteriophag
fdova
gener
clone
dna
fragment
encod
ova
siinfekl
mhc
b
restrict
cytotox
peptid
saciistyidigest
phage
genom
previous
describ
e
coli
mrf
kan
cell
transform
recombin
bacteriophag
produc
hybrid
phage
supernat
wild
type
fdwt
recombin
virion
harvest
bacteria
cultur
medium
purifi
caesium
chlorid
gradient
analyz
sdspage
describ
elsewher
number
copi
pviii
display
ova
peptid
determin
ntermin
sequenc
analysi
phage
prepar
concentr
antigen
peptid
fdova
bacteriophag
calcul
copi
number
modifi
pviii
hybrid
virion
singl
hybrid
phage
prepar
fdova
carri
ova
peptid
display
recombin
copi
major
coat
protein
pviii
total
mice
sensit
one
inject
cytotox
ova
siinfekl
peptid
helper
hbvc
tppayrppnapil
peptid
hepat
b
viru
core
antigen
emulsifi
incomplet
freund
adjuv
sigma
milan
itali
eightweekold
femal
mice
purchas
harlan
nossan
corezzana
itali
maintain
igb
anim
facil
accord
institut
guidelin
sentinel
mice
screen
seroposit
sendai
viru
rodent
coronaviru
mycoplasma
pulmoni
murin
immunocomb
test
charl
river
lecco
itali
found
neg
experi
mice
perform
accord
european
union
law
guidelin
anim
studi
approv
institut
review
board
anim
procedur
ie
immun
sacrific
perform
accord
rule
approv
ethic
committe
peptid
purchas
primm
milan
itali
puriti
analyz
hplc
mass
spectrometri
ten
day
sensit
dth
perform
inject
antigen
right
footpad
pb
left
footpad
hour
later
area
swell
measur
use
calip
dth
reaction
elicit
mice
inject
respect
fdova
display
ova
peptid
fdwt
ova
synthet
peptid
fdwt
plu
ova
synthet
peptid
pure
solubl
ovalbumin
sigma
milan
itali
immun
rat
antimous
mab
purifi
hybridoma
atcc
manassa
va
usa
cultur
supernat
affin
chromatographi
hitrap
prote
column
amershampharmacia
freiburg
germani
treatment
deplet
mab
perform
ip
previous
describ
day
everi
day
boost
mab
boost
assay
longterm
respons
treatment
mab
repeat
weekli
basi
noncompet
fitcconjug
mab
clone
bd
pharmingen
milan
itali
use
vivo
cell
deplet
assess
effici
cell
deplet
control
fac
analysi
facsaria
becton
dickinson
spleen
cell
isol
repres
mice
sacrif
variou
time
point
immun
perform
day
use
fdova
administ
either
subcutan
without
adjuv
intraperiton
presenc
poli
c
accord
follow
protocol
group
fdova
group
b
fdova
plu
mab
group
c
fdova
plu
poli
c
adjuv
group
untreat
mice
mice
sacrif
week
boost
two
month
later
singl
splenocyt
suspens
prepar
mechan
disrupt
either
control
immun
mice
respond
cell
test
antiova
peptid
cytotox
respons
jam
test
briefli
respond
cell
cell
per
well
stimul
plate
irradi
syngen
femal
spleen
cell
stimul
cell
per
well
prepuls
ova
peptid
presenc
uml
posit
control
spleen
cell
mous
stimul
parallel
cultur
irradi
balbc
femal
spleen
cell
bear
alloantigen
antiallo
respons
day
cell
harvest
test
cytotox
activ
htdr
label
target
assay
antiova
peptid
respond
cell
test
target
cell
b
syngen
mice
either
prepuls
ova
peptid
antiallo
respond
cell
test
either
target
cell
respond
cell
prepar
either
control
immun
mice
cell
incub
mab
precoat
multiscreen
plate
uml
irradi
syngen
spleen
cell
prepuls
either
ova
medium
alon
respond
cell
well
mous
incub
either
medium
alon
cona
ngml
hour
incub
c
cell
wash
plate
sequenti
incub
biotinyl
mab
polyhrpstreptavidin
endogen
woburn
usa
aec
substrat
sigma
milan
itali
transfect
tsa
cell
parent
journal
biomedicin
biotechnolog
untransfect
line
use
control
elispot
plate
gamma
irradi
spot
count
use
elispot
reader
aelvi
hannov
germani
statist
analys
perform
use
unpair
student
ttest
differ
consid
statist
signific
p
evok
delay
type
hypersensit
reaction
dth
order
verifi
fd
bacteriophag
could
use
vehicl
monitor
presenc
antigenspecif
cell
set
experiment
model
reproduc
prior
exposur
antigen
sensit
mice
inject
base
tail
mixtur
ova
cytotox
peptid
hbvc
helper
peptid
incomplet
freund
adjuv
model
develop
dth
normal
take
day
time
immun
dth
reaction
gener
inject
mice
recombin
fdova
mice
wild
type
fd
filament
bacteriophag
fdwt
five
mice
ova
peptid
five
mice
solubl
ovalbumin
right
footpad
left
footpad
instead
treat
volum
pb
figur
show
measur
footpad
swell
mean
sd
differ
time
point
respons
dth
skin
test
valu
pb
background
subtract
point
signific
swell
hour
induc
footpad
mice
challeng
fd
ova
virion
contrast
dth
reaction
observ
mice
challeng
wild
type
phage
synthet
ova
peptid
solubl
ovalbumin
result
indic
dth
reaction
trigger
fd
virion
display
ova
epitop
dth
thu
induc
ova
specif
cell
figur
b
summar
mean
increas
thick
mice
group
hour
mice
inject
fdova
show
mean
mm
footpad
swell
compar
mm
footpad
swell
mice
inject
fdwt
group
challeng
synthet
peptid
solubl
ovalbumin
show
signific
swell
mean
effect
elicit
dth
reaction
mention
dth
induc
administr
fdova
absenc
adjuv
statist
analysi
student
ttest
reveal
differ
dth
induc
fdova
respect
dth
induc
challeng
signific
p
figur
b
use
synthet
ova
peptid
presenc
fdwt
elicit
dth
data
shown
indic
dth
confer
antigen
determin
display
phage
surfac
induct
dth
fdova
virion
could
ascrib
presenc
lp
contamin
phage
prepar
sinc
amount
lp
present
fdova
fdwt
sampl
goal
determin
whether
respons
singl
hybrid
bacteriophag
carri
ctl
epitop
fdova
could
gener
maintain
absenc
cell
administ
fdova
without
adjuv
mice
deplet
lymphocyt
antibodi
treatment
measur
secondari
cytotox
respons
specif
immun
group
mice
accord
follow
protocol
fdova
b
fdova
plu
c
fdova
plu
poli
c
untreat
mice
use
control
figur
summar
result
obtain
group
mice
figur
show
percentag
specif
lysi
subtract
background
lysi
unpuls
target
respondertarget
ratio
figur
b
show
elispot
assay
measur
frequenc
produc
splenocyt
respons
vitro
stimul
ova
synthet
peptid
result
indic
filament
bacteriophag
administ
without
adjuv
abl
induc
relev
antigenspecif
ctl
mean
lysi
product
mean
spot
form
cell
sfc
million
cell
although
respons
lower
obtain
fdova
administ
presenc
poli
c
adjuv
lysi
sfcmillion
cell
deplet
lymphocyt
lytic
activ
product
antigenspecif
cell
lower
lytic
activ
sfc
cell
obtain
presenc
cell
differ
statist
signific
p
presenc
ctl
cell
deplet
mice
indic
secondari
expans
sinc
singl
administr
fdova
particl
suffici
induc
ctl
activ
data
shown
group
mice
also
immun
fdova
without
adjuv
treat
mab
two
month
boost
order
establish
lymphocyt
necessari
induc
longterm
memori
cell
respons
illustr
figur
c
observ
antigenspecif
immun
respons
either
cytotox
test
elispot
assay
mice
contrast
longterm
respons
posit
control
statist
analysi
confirm
signific
differ
fdova
fdova
mice
group
either
lytic
activ
p
product
p
effici
cell
deplet
control
fac
analysi
spleen
cell
isol
mice
treat
antibodi
differ
time
point
treatment
day
first
immun
day
boost
two
week
boost
shortterm
memori
two
month
later
longterm
memori
data
illustr
figur
e
show
cell
deplet
mice
treat
mab
agreement
data
previous
report
percentag
spleen
cell
similar
mice
deplet
data
shown
conclus
shortterm
secondari
respons
follow
fdova
immun
independ
cell
help
longterm
secondari
respons
helper
depend
observ
follow
fdova
immun
mice
deplet
lymphocyt
cellular
immun
particularli
cytotox
lymphocyt
activ
play
role
clearanc
viral
infect
control
tumor
develop
therefor
induct
ctl
activ
major
goal
vaccin
develop
achiev
may
determin
abil
carrier
deliv
antigen
mhc
class
pathway
report
studi
use
fd
filament
bacteriophag
effici
carrier
deliv
ctl
epitop
bacteriophag
fd
nonpathogen
viru
abl
infect
replic
eukaryot
cell
avail
evid
indic
bacteriophag
administr
complet
harmless
human
past
year
shown
fd
bacteriophag
particl
repres
good
antigen
deliveri
system
helper
ctl
epitop
sinc
particl
intersect
class
class
ii
pathway
paper
show
fd
particl
also
use
induc
dth
reaction
may
allow
vivo
monitor
immun
respons
mediat
antigenspecif
cell
previous
report
studi
fd
virion
use
sensit
mice
induc
dth
reaction
use
fd
virion
challeng
dth
mice
sensit
administr
combin
synthet
helper
ctl
peptid
thu
prove
fd
bacteriophag
abl
stimul
tissu
ova
specif
lymphocyt
prime
differ
deliveri
ova
antigen
determin
dth
reaction
skin
observ
mani
immunotherapi
protocol
often
use
indic
antitumor
immun
viru
vaccin
efficaci
addit
sinc
dth
rel
straightforward
perform
may
employ
preliminari
screen
diagnost
viru
infect
may
serv
vivo
measur
lymphocyt
traffick
site
infect
also
analyz
role
cell
induct
fd
virion
ctl
memori
respons
previous
describ
display
ctl
epitop
ova
siinfekl
surfac
fd
virion
suffici
sustain
mhc
class
restrict
cytotox
lymphocyt
respons
vivo
assess
vivo
crosspresent
ova
epitop
display
bacteriophag
aim
investig
cellular
mechan
carrier
employ
stimul
ctl
induct
import
specif
cell
help
cell
mediat
immun
known
howev
interact
cross
present
dc
cell
cell
establish
immunolog
memori
still
well
defin
previou
studi
confirm
helper
cell
requir
secondari
induct
ctl
vitro
vivo
sinc
cell
deplet
caus
complet
disappear
antigenspecif
ctl
secondari
stimul
context
find
interest
fact
determin
fd
particl
carri
ova
peptid
journal
biomedicin
biotechnolog
still
abl
induc
secondari
expans
ova
ctl
even
absenc
cell
suggest
altern
thindepend
pathway
ctl
activ
may
oper
via
recognit
molecular
pattern
recognit
receptor
prr
dc
turn
initi
signal
cascad
activ
dc
provid
cell
costimul
cytokin
releas
particular
report
small
amount
produc
also
dc
addit
exogen
mice
deplet
cell
restor
secondari
expans
ctl
plan
investig
futur
work
abil
phage
function
prr
agonist
induc
cytokin
product
matur
dc
upregul
costimolatori
molecul
studi
report
presenc
cell
essenti
induc
secondari
memori
respons
presenc
instead
requir
elicit
longterm
memori
respons
fd
antigen
deliveri
find
journal
biomedicin
biotechnolog
taken
consider
design
fd
particl
vaccin
strategi
overal
analysi
cellular
mechan
employ
fd
virion
contribut
toward
defin
potenti
safe
inexpens
antigen
deliveri
system
propos
subunit
vaccin
abl
improv
antigen
immunogen
antigen
determin
display
show
fd
particl
display
ctl
epitop
synthet
peptid
use
without
adjuv
activ
antigenspecif
cell
tissu
evok
dth
reaction
result
suggest
fd
bacteriophag
use
diagnost
tool
vivo
monitor
infect
presenc
antigenspecif
cell
moreov
sinc
fd
system
appli
vaccin
formul
defin
role
cell
induct
longterm
memori
respons
found
presenc
cell
requir
sustain
longterm
induct
ctl
context
fd
system
coactiv
cell
easili
achiev
type
mhcrestrict
antigen
construct
doubl
hybrid
bacteriophag
display
helper
ctl
epitop
virion
